Jan 13 (Reuters) - The South Carolina health department reported 434 measles cases related to the ongoing outbreak in the ...

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

The beauty of baseball is that nothing is truly certain. With that in mind, David Singh gives us his MLB bold predictions for ...

If you were at Newark Airport's Terminals B and C on December 19 and you're not vaccinated, you may have been exposed to the measles, state health officials warn.

Now, before I get into it, I will preface this review by saying my liver was fine to begin with. And if my liver were to give me issues, I would go to a doctor (as you should too!) before ever turning ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start of therapy to help patients and care partners treat this ...

Sept 23 (Reuters) - The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen's (BIIB.O), opens new tab drug for a rare genetic disorder that causes progressive ...

Background Seizures and agitation are distressing symptoms commonly encountered at the end of life and may require treatment with phenobarbitone when standard therapies fail. Current phenobarbitone ...

The RxPonder trial showed that postmenopausal patients with hormone receptor-positive (HR+) breast cancer and up to three involved lymph nodes who have an Oncotype score <25 do not benefit from ...

Creatine is one of the most widely used dietary supplements for improving exercise performance. It provides the muscles with energy for short-term, high-intensity workouts like weight lifting. It may ...

A higher-dose regimen of nusinersen, currently up for approval in the U.S., may provide further benefits to people with spinal muscular atrophy (SMA) relative to the approved Spinraza regimen, ...

New data from Biogen shows improved motor function in SMA patients using a higher dose of nusinersen, highlighting early treatment benefits. Biogen announced new data from the DEVOTE Part C and ...